{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:51:28Z","timestamp":1793958688742,"version":"4.8.0"},"reference-count":14,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/03007995.2024.2352856","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:48:41Z","timestamp":1715755721000},"page":"1053-1058","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study"],"prefix":"10.1080","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-1819","authenticated-orcid":false,"given":"Benjamin A.","family":"Derman","sequence":"first","affiliation":[{"name":"University of Chicago Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-0020","authenticated-orcid":false,"given":"Meaghan","family":"Roach","sequence":"additional","affiliation":[{"name":"PRECISIONheor, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee","family":"Lin","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, Horsham, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcao","family":"Wu","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, Horsham, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Murphy","sequence":"additional","affiliation":[{"name":"PRECISIONheor, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kim","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, Horsham, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Doyle","sequence":"additional","affiliation":[{"name":"Janssen Sciences Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadya","family":"Prood","sequence":"additional","affiliation":[{"name":"PRECISIONheor, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fowler","sequence":"additional","affiliation":[{"name":"Janssen US Medical Affairs, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marshall","sequence":"additional","affiliation":[{"name":"Janssen Global Services, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Jamaleddine","sequence":"additional","affiliation":[{"name":"PRECISIONheor, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agne","family":"Paner-Straseviciute","sequence":"additional","affiliation":[{"name":"Janssen US Medical Affairs, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"FDA approves teclistamab-cqyv for relapsed or refractory multiple myeloma [Internet]; 2022. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-teclistamab-cqyv-relapsed-or-refractory-multiple-myeloma."},{"key":"e_1_3_5_3_1","unstructured":"European Medicines Agency. New medicine for multiple myeloma patients with limited treatment options 2022 [9\/15\/2023]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/new-medicine-multiple-myeloma-patients-limited-treatment-options."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)00857-1"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_3_5_6_1","unstructured":"U.S. Food & Drug Administration. TECVAYLI\u2122 (teclistamab-cqyv) injection for subcutaneous use. 2022."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8011"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.1533"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01471-4"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00159-6"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00879-7"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000970548.43149.cb"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34756"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0049"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8034"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2352856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:06:44Z","timestamp":1727190404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2352856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/03007995.2024.2352856"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2352856","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}